Cancer patients are testing a medicine made of antibodies that were designed from scratch on a computer in Israel and whose inventor has “programmed” them to “decide” whether cells surrounding tumors are bad or good.
If the trial, which is underway in Australia, goes according to plan, these antibodies will fight cells that help the tumor while boosting the abilities of cells that inhibit cancer growth.
Their inventor, Prof. Yanay Ofran, said that until now, antibody treatments have been based on human or animal antibodies. They are then developed in labs and mass produced, but the final product retains limitations from the original antibodies.
“Antibodies are very successful, but the way they are used in medicine today utilizes only a fraction of their capability,” he told The Times of Israel. “Our mission is to take antibodies and seize on the fact they are safe, stable, easy to use and can stay on the shelf for years, to unlock their full ability.”
Ofran, a Bar Ilan University professor, has published numerous peer-reviewed studies on his method of designing antibodies on a computer. They emphasize the “smart” quality of the new antibodies.
This means that instead of carrying out a single function, like fighting a single virus, they can survey their surroundings and act in different ways when faced with different types of cells. Ofran refers to them as “nano-robots.”
The new AU-007 antibody treatment is the first computer-designed antibody to enter a human trial, he said. It was designed by artificial intelligence software at the Rehovot offices of his startup Biolojic Design, and is being trialed by its spin-out company Aulos Bioscience. Biolojic is now working on several other treatments.
Ofran’s breakthrough results from a laborious research process, which involves creating many millions of antibodies and monitoring their behavior in the lab.
His team’s artificial intelligence software analyzes the data on how the antibodies behave. “We learn from the observations we collect how to create a new antibody that will do exactly what we want it to do,” said Ofran.
AU-007 uses antibodies that can “feel” or “sense“ their surroundings and differentiate between cells that are likely to help or hinder a tumor based on features on the cell’s exterior such as cilia, which are protruding antenna-like structures.
“What we’re doing is to use the antibody to identify the cells they meet, and activate cells that can attack the tumor while stopping cells that help the tumor,” Ofran explained.
Ofran is a descendent of one of Israel’s best-known scientists. His grandfather Prof. Yeshayahu Leibowitz, while most remembered for his religious and political writing, was a professor of organic chemistry and neurology, and a leader in those fields during Israel’s early decades.
Ofran hopes that his work will change scientists’ understanding of the potential of antibodies. Today they are generally deployed to perform a single task — for example, to neutralize coronavirus. As he puts it, they are “one-trick ponies.”
Designing antibodies by computer opens up the possibility of making them multi-function, as illustrated by AU-007’s ability to boost cancer-fighting cells but do the opposite with cells that help cancer.
“Instead of just seeking out one environment and reacting always with the same response, we’re producing antibodies that can act conditionally, meaning if the cells appear one way they do ‘x,’ and if they look another way they do ‘y,’” Ofran said.
“This opens up the door to smarter therapeutics that can execute sophisticated plans to cure disease.”
News
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
